AstraZeneca (AZN) Pharma and Biotech Sector

  • Latest quote

    5,860.00p (mid)

  • Current Change (%)

    1.54%

  • Price

    Bid: 5,852.00p

    Offer: 5,853.00p

  • Today

    High: 5,925.00p

    Low: 5,804.00p

  • This year

    High: 6,107.00p

    Low: 4,705.00p

  • Information

    Volume: 1,324,241

    Market Cap: £74098.98M


AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
FDA Orphan Drug for Lynparza in pancreatic cancer 07:00 - October 16, 2018
Total Voting Rights 15:00 - October 1, 2018
Atacand Agreement with Cheplapharm Completed 07:00 - October 1, 2018
Previous Announcement Regarding Appointment Of NED 16:00 - September 28, 2018
Overall survival data for Imfinzi: Stage III NSCLC 13:15 - September 25, 2018
EMA approves AZ's Imfinzi for Stage III NSCLC 16:10 - September 24, 2018
Farxiga gets positive result in DECLARE-TIMI 58 07:00 - September 24, 2018
FDA approves AZ's Lumoxiti in hairy cell leukaemia 07:00 - September 14, 2018
Tezepelumab FDA Breakthrough Therapy Designation 07:00 - September 7, 2018
Directorate Change 07:00 - September 6, 2018
Total Voting Rights 15:00 - September 3, 2018
AstraZeneca Update on Anifrolumab in SLE 07:00 - August 31, 2018
EC approves Bydureon BCise device for T2 diabetes 07:00 - August 30, 2018
AstraZeneca PIIIb trial update for Bevespi in COPD 07:00 - August 23, 2018
AZ's Tagrisso approved in Japan for 1st-line NSCLC 07:00 - August 21, 2018

NOTE: This is based on 174 open tips for this company


Total Number of Share tips :

369

View all AstraZeneca Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today